MetaCap

DataMeds AI (MEDS) vs 111 (YI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

111 is the larger company by market cap ($27.6 million vs $9.6 million), about 2.9 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

MEDS versus YI key metrics
MetricMEDSYI
Share price$3.40$3.14
Market cap$9.63M$27.62M
1-day change+18.06%-0.32%
YTD return—+23.05%
1-year return—-33.12%
5-year return—-44.25%
P/E ratio (TTM)—0.31
Forward P/E—22.43
EPS (TTM)$-46.68$10.00
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$73.00$11.17
52-week low$0.823$2.48
Distance from 52-week high-95.34%-71.89%
Average volume5.82M11.12K
Shares outstanding2.83M5.20M
Employees—1,063
SectorHealthcareHealthcare
IndustryMedical DistributionMedical Distribution

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • 111 is about 2.9 times larger than DataMeds AI by market value ($27.62M vs $9.63M).

About DataMeds AI

MEDS stock →

DataMEDS AI, Inc. operates as a health IT company in the United States.

Healthcare · Medical Distribution

About 111

YI stock →

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B.

Healthcare · Medical Distribution · 1,063 employees

MEDS vs YI FAQ

Which is bigger, DataMeds AI or 111?

111 (YI) is larger, with a market capitalization of $27.62M compared with $9.63M for DataMeds AI (MEDS).

Are DataMeds AI and 111 in the same industry?

Yes. Both are classified in the Medical Distribution industry within the Healthcare sector.

More comparisons